Caloxa 50 mg Tablets
PDF Leaflet Revision Date: 31 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of advanced prostate cancer.
Dosage (summary)
One tablet (50 mg) once daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; contraindicated in pregnant or breastfeeding women.
Key Drug Interactions
- LHRH analogues
- Ketoconazole
- Cimetidine
- Warfarin
Contraindications
- Females
- Children
- Pregnant women
- Breastfeeding mothers
- Hypersensitivity
Common side effects
- Anaemia
- Dizziness
- Somnolence
- Myocardial infarction
- Hypertension
Counselling Points
- Monitor for liver function changes.
- Avoid driving if experiencing somnolence.
- Report any severe side effects.
Serious warnings
- Hepatic impairment may increase toxicity.
- Periodic liver function testing recommended.
Important Disclaimer
The Caloxa 50 mg Tablets professional information leaflet below is the property of Eurolab and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
